A physician scientist and senior executive with 25+ year biomedical research and biopharmaceutical R&D experience in oncology, form discovery, translational medicine to clinical development

Served as SVP and Head of Clinical Development at BeiGene, built BeiGene's clinical team and led the clinical development of 4 oncology assets from Phase I to pivotal trials including the first China-developed anti-PD-1 mAb

Led the research and development of over 10 oncology assets while serving as Oncology Medical Director at Covance (U.S.), Senior Principal Scientist in cancer translational medicine at Pfizer (U.S.) and Research Scientist in cancer genomics at Tularik/Amgen (U.S.)

Ph.D. from UT Southwestern Medical Center; postdoctoral fellowship at Harvard University; M.D. from Hubei Medical College

Over 20 years of experience in global oncology development and scientific research

Executive Director of Oncology Early Development at Merck(MSD) where he oversaw the development of 10+ oncology products from preclinical to proof-of-concept stage

Leader of the Oncology Team of Excellence for Strategy in Therapeutic Area at Daiichi-Sankyo where he led Phase III trial for pexidartinib

Faculty as Assistant Member at Memorial Sloan-Kettering Cancer Center and Assistant Professor at Weill Cornell Medical School

M.D and Ph.D. in Biochemistry & Molecular Biology from the University of Southern California; fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center and board-certified medical oncologist

More than 16 years of working experience in China’s pharmaceutical industry at multinational corporations and global strategy consulting firms，with extensive experience in oncology and rare diseases

Servered as the Chief Marketing Officer at Sanofi Pasteur (China), led a 4-pillar-consisted team to successfully deliver multiple innovative signature programs

Worked at Novartis Oncology for 8 years and served successively as Head of Rare Disease Franchise and BU Head of Oncology Established Brands. He was in charge of several hundreds of millions of US dollars in business, successfully drove the growth of rare disease brands through precision diagnostics and market education, and introduced innovative business models to ensure sustained growth of mature brands

M.D. from Peking Union Medical College

Over 23 years of experience in biopharmaceutical strategy and business development, and achieved more than 40 transactions across six continents totaling multiple billion dollars in transaction value

Leadership experience across all parts of the business development value chain from strategy, search and evaluation, negotiation and deal structuring to execution and alliance management

Business Alliance Lead for US, Latin America, Asia-Pacific, Japan, and China at Pfizer Essential Health

Extensive capital markets experience including fund raising and launching new companies

Over 20 years of experience across all financial functions with exposure to both biotech and MNCs

Served as Vice President Finance at HUTCHMED (China) Limited, and led the team to support the NASDAQ and HK IPO process for the company

Worked for multinational companies including Nestle (China) and SIMPLOT (Australia)

Bachelor’s degree from South China Agricultural University and a member of CPA Australia